Head-to-head · WeighScore
LillyDirect Foundayo vs TOM Weight Loss
The verdict
LillyDirect Foundayo takes it — 67.2/100 to 66.3/100, but only just.
LillyDirect Foundayo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss. TOM Weight Loss is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | LillyDirect Foundayo | TOM Weight Loss |
|---|---|---|
| WeighScore | 67.2/100 | 66.3/100 |
| Grade | C | C |
| Scorecard rank | #165 | #193 |
| Semaglutide | Not disclosed | $199/mo (all doses, compounded) |
| Tirzepatide | Not disclosed | $249/mo (all doses, compounded) |
| Coverage | All 50 states | 2 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #165 · C
Strengths
- Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
- Direct from manufacturer — no compounding, no third-party reseller
- Daily oral pill, no injections, no refrigeration
- Available in all 50 states
Where it loses points
- Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
- Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
- $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
- Strict empty-stomach 30-minute window may be hard for some patients to follow
Graded #193 · C
Strengths
- ABOM board-certified physician (Dr. Tran Le, NPI 1194212258, verified ACTIVE)
- Solo-physician model — every patient sees Dr. Le directly
- Flat-rate pricing — no dose escalation surcharge
- LegitScript badge displayed
- No FDA Warning Letters
Where it loses points
- Limited geographic footprint — Texas and Utah only
- No named compounding pharmacy partner disclosed
- Compounded medications are not FDA-approved
- Cash-pay only, no insurance
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.